Biostatistical support to advance prostate cancer research and cancer detection models
Official title: Statistical modeling to support population and translational cancer research
Funded at Fred Hutchinson Cancer Center · NIH-11415752 · Data updated 2026-11-12
A biostatistics-focused NIH grant supports a team in using data, modeling, and software to improve prostate cancer research and test new cancer-detection approaches.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | September 20, 2017 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $245,182 |
| NIH project number | 5R50CA221836-10 |
| Project ID | NIH-11415752 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to this grant as described; the project is largely methodological and programmatic in biostatistics and modeling rather than enrolling participants.
✕Less likely to help
There is no direct patient enrollment in this grant; the benefits are through improved diagnostics and policies that may affect future patients.
What this research studies
This grant funds biostatistical analysis and computer modeling for a multi-project translational prostate cancer program, plus a cancer surveillance effort that uses biomathematical models to inform population policies. It also leads a Data Modeling and Analytics Core that will evaluate how well new diagnostic technologies work and how early detection tests perform across cancers. The work aims to bridge basic science, clinical trials, and population health by applying rigorous methods to interpret results and bracket uncertainty. Strong collaboration and clear communication will help translate scientific findings into practical strategies for cancer control.
Why it matters
Potential benefit: If successful, the work could improve the accuracy of cancer diagnostics, inform policy decisions, and accelerate the translation of research findings into better cancer care.
How similar studies have gone: Previous projects demonstrated valuable statistical support across prostate cancer studies, with modeling and analysis guiding clinical and population-level insights.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Gulati, Roman — Fred Hutchinson Cancer Center
- Study coordinator: Gulati, Roman
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.